{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:21:45Z","timestamp":1790014905419,"version":"4.0.1"},"reference-count":58,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"LiGalli"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Drug Delivery"],"published-print":{"date-parts":[[2023,12,31]]},"DOI":"10.1080\/10717544.2023.2180113","type":"journal-article","created":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T02:59:20Z","timestamp":1677121160000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":13,"title":["First-in-human study to assess the pharmacokinetics, tolerability, and safety of single-dose oxybutynin hydrochloride administered via a microprocessor-controlled intravaginal ring"],"prefix":"10.1080","volume":"30","author":[{"given":"Willem","family":"de Laat","sequence":"first","affiliation":[{"name":"LiGalli","place":["The Hague, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2064-7501","authenticated-orcid":false,"given":"Lisa","family":"Pagan","sequence":"additional","affiliation":[{"name":"Centre for Human Drug Research","place":["Leiden, The Netherlands"]},{"name":"Department of Gynaecology and Obstetrics, Leiden University Medical Centre","place":["Leiden, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1276-7095","authenticated-orcid":false,"given":"R. Karl","family":"Malcolm","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Queen\u2019s University Belfast","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8683-5767","authenticated-orcid":false,"given":"Maarten","family":"Wiegerinck","sequence":"additional","affiliation":[{"name":"LiGalli","place":["The Hague, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Nickolson","sequence":"additional","affiliation":[{"name":"LiGalli","place":["The Hague, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0807-0658","authenticated-orcid":false,"given":"Bertine","family":"Huisman","sequence":"additional","affiliation":[{"name":"Centre for Human Drug Research","place":["Leiden, The Netherlands"]},{"name":"Department of Gynaecology and Obstetrics, Leiden University Medical Centre","place":["Leiden, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0013-8355","authenticated-orcid":false,"given":"Rik","family":"Stuurman","sequence":"additional","affiliation":[{"name":"Centre for Human Drug Research","place":["Leiden, The Netherlands"]},{"name":"Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre","place":["Leiden, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8159-0273","authenticated-orcid":false,"given":"Michiel","family":"van Esdonk","sequence":"additional","affiliation":[{"name":"Centre for Human Drug Research","place":["Leiden, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Klarenbeek","sequence":"additional","affiliation":[{"name":"Centre for Human Drug Research","place":["Leiden, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,2,22]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26195905"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2006.07.004"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2004.01.025"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/13625187.2017.1413179"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.4065\/78.6.696"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506110"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0028-2243(93)90252-8"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125682"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2019.10.015"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118574"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2021.100091"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.2147\/ciia.2006.1.2.99"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/13625187.2021.1884219"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1021\/am300502r"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-015-9432-2"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)60721-3"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.2165\/11588990-000000000-00000"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00558247"},{"key":"e_1_3_5_20_1","unstructured":"Drugbank. 2023. Oxybutynin. Available at: https:\/\/go.drugbank.com\/drugs\/DB01062. Accessed January 25 2023."},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2020.06.006"},{"key":"e_1_3_5_22_1","unstructured":"Electronic Medicines Compendium (2023). Summary of product characteristics for Oxybutynin hydrochloride tablets 2.5 mg. Available at: https:\/\/www.medicines.org.uk\/emc\/product\/14309\/smpc [accessed 2023 Feb 18]."},{"key":"e_1_3_5_23_1","volume-title":"StatPearls","author":"Flores SA","year":"2022","unstructured":"Flores SA, Hall CA. 2022. Atrophic vaginitis. In: StatPearls. Treasure Island (FL): StatPearls Publishing."},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2013.11.019"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2017.09.044"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2012.688953"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.2174\/187221111795471418"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-18646"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(96)70378-2"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2008.08.012"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2004.11.034"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.2174\/1872211313666190215141507"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00192-012-1915-8"},{"key":"e_1_3_5_34_1","first-page":"12","article-title":"A comparative review of oxybutynin chloride formulations: pharmacokinetics and therapeutic efficacy in overactive bladder","volume":"12","author":"Kennelly MJ.","year":"2010","unstructured":"Kennelly MJ. (2010). A comparative review of oxybutynin chloride formulations: pharmacokinetics and therapeutic efficacy in overactive bladder. Rev Urol 12:12\u20139.","journal-title":"Rev Urol"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2013.05.011"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1809"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25747"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1080\/13625187.2017.1287351"},{"key":"e_1_3_5_39_1","first-page":"CD003552","article-title":"Skin patch and vaginal ring versus combined oral contraceptives for contraception","volume":"2013","author":"Lopez LM","year":"2013","unstructured":"Lopez LM, Grimes DA, Gallo MF, et\u00a0al. (2013). Skin patch and vaginal ring versus combined oral contraceptives for contraception. Cochrane Database Syst Rev 2013:CD003552.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_5_40_1","first-page":"116","article-title":"The evolution of transdermal\/topical overactive bladder therapy and its benefits over oral therapy","volume":"2","author":"MacDiarmid SA.","year":"2009","unstructured":"MacDiarmid SA. (2009). The evolution of transdermal\/topical overactive bladder therapy and its benefits over oral therapy. Rev Obstet Gynecol 2:116\u201321.","journal-title":"Rev Obstet Gynecol"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2016.01.015"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.21793"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2018.1519549"},{"key":"e_1_3_5_44_1","first-page":"13","article-title":"Vaginal absorption of penicillin","volume":"105","author":"Rock J","year":"1947","unstructured":"Rock J, Barker RH, Bacon WB. (1947). Vaginal absorption of penicillin. Tech Pap 105:13.","journal-title":"Tech Pap"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(00)00782-2"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.51201\/JUSST\/21\/121047"},{"key":"e_1_3_5_47_1","first-page":"93","article-title":"Management of overactive bladder with transdermal oxybutynin","volume":"8","author":"Starkman JS","year":"2006","unstructured":"Starkman JS, Dmochowski RR. (2006). Management of overactive bladder with transdermal oxybutynin. Rev Urol 8:93\u2013103.","journal-title":"Rev Urol"},{"issue":"8","key":"e_1_3_5_48_1","first-page":"S26","article-title":"Transdermal systems for overactive bladder: principles and practice","volume":"5","author":"Staskin DR.","year":"2003","unstructured":"Staskin DR. (2003). Transdermal systems for overactive bladder: principles and practice. Rev Urol 5(Suppl 8):S26\u2013S30.","journal-title":"Rev Urol"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2013.02.1961"},{"key":"e_1_3_5_50_1","volume-title":"R: a language and environment for statistical computing","author":"The R Core Team","year":"2020","unstructured":"The R Core Team. 2020. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing. Available at: https:\/\/www.R-project.org [accessed 2023 Jan 18]."},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001648"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120290"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200039030-00005"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2013.09.003"},{"key":"e_1_3_5_55_1","unstructured":"U.S. Food & Drug Administration. (2023). FDA Database: Inactive Ingredient Search for Approved Drug Products. Available at: https:\/\/www.accessdata.fda.gov\/scripts\/cder\/iig\/index.cfm [accessed 2023 Jan 18]."},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-3659(03)00277-3"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2018.04.010"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-199506030-00007"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1022259011052"}],"container-title":["Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10717544.2023.2180113","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T10:21:40Z","timestamp":1780914100000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10717544.2023.2180113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,22]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,12,31]]}},"alternative-id":["10.1080\/10717544.2023.2180113"],"URL":"https:\/\/doi.org\/10.1080\/10717544.2023.2180113","relation":{},"ISSN":["1071-7544","1521-0464"],"issn-type":[{"value":"1071-7544","type":"print"},{"value":"1521-0464","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=idrd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=idrd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-12-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2180113"}}